GNGalina N. Nikiforova

Galina N. Nikiforova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Galina N. Nikiforova has a total of 138 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Optimizing the treatment of patients with acute non-streptococcal tonsillopharyngitis: focusing on the impact on all stages of the etiopathogenesis

    by V.M. Svistushkin, G.N. Nikiforova, A.B. Maltsev, A.V. Zolotova, A.N. Shustrova, A.R. Mironova

    Acute tonsillopharyngitis (ATP) is one of the most common reasons for patients seeking primary care in both pediatric and adult practice. This disease is characterized by inflammatory changes in the mucosa and lymphatic structures of the oropharynx. The etiological structure of ATP is heterogeneous, but viruses play a leading role. Despite the long-term scientific and practical interest of doctors in the study of etiopathogenesis and the treatment of patients with this pathology, a significant number of diagnostic and therapeutic errors remain in real clinical practice, leading to polypharmacy and, first of all, to the unjustified prescription of systemic antibacterial drugs. These circumstances contribute to the suppression of the normal microbiota of the human body, an increase in antibiotic resistance of pathogens, an increase in the cost of treatment and the risk of adverse drug reactions. In acute non-streptococcal tonsillopharyngitis, antibacterial therapy is not indicated. Treatment of such patients should be directed to all links of etiopathogenesis, with the minimum sufficient use of drugs. Patients with viral ATP need effective relief of symptoms and prevention of bacterial complications. In this aspect, standardized herbal medicine can play an important role. Herbal drugs have a multicomponent effect, including anti-inflammatory, antiseptic, immunomodulatory and reparative effects. This makes them optimal agents for the therapy of viral inflammatory diseases of the pharynx. Particular attention should be paid to Tonsilgon N—the original herbal medicinal product with complex effect, produced by Bionorica company in Germany according to the unique concept of phytoneering. The staff of the Department of Ear, Throat and Nose Diseases of the Sechenov Moscow State Medical University studied the effectiveness of the Tonsilgon N use in the treatment of patients with acute non-bacterial tonsillopharyngitis. The results of the study showed that the use of Tonsilgon H in the treatment of patients with acute non-bacterial tonsillopharyngitis is safe and effective, and contributes to a faster reduction in the severity of clinical symptoms compared to the use of topical therapy alone.

  • Open Access

    Common Carotid Artery Extra-Media Thickness as a Marker of Perivascular Obesity and Cardiometabolic Risk in Individuals Without Cardiovascular Disease

    by Anna Bragina, Natalia Druzhinina, Yulia Rodionova, Daria Akvitskaya, Kirill Novikov, Galina Nikiforova, Oksana Avdeenko, Natalia Vlasova, Alina Arzukanyan, Alina Kudravceva, et al.

    Background: Perivascular adipose tissue (PVAT) is increasingly recognized as a pathogenetic contributor to vascular dysfunction. Carotid extra-media thickness (EMT) measured by ultrasound is the simplest, noninvasive and clinically accessible marker of PVAT deposition. However, reference values in young individuals without cardiovascular disease (CVD) are lacking. The aim of this study was to analyze the relationship between carotid EMT and cardiovascular risk factors and to determine a tentative reference value of carotid EMT in individuals without CVD. Methods: This cross-sectional study included 373 patients with a median age of 23 (21; 32) years and without CVD. All patients underwent anthropometric examination, lipid-profile assessment using the CardioChek PA (USA, 2020), and duplex ultrasound of the brachiocephalic arteries with measurement of common carotid artery EMT and intima-media thickness (IMT). A subgroup of apparently healthy individuals without cardiovascular risk factors was selected to define a threshold. EMT above the 90th percentile of this subgroup was regarded as perivascular obesity (PVO). Results: Carotid EMT was significantly associated with age, blood pressure levels, anthropometric and laboratory metabolic markers, glycemia and smoking. On multivariable linear regression, age, obesity and smoking were independently associated with EMT. The 90th percentile threshold in the apparently healthy subgroup (n = 185) was 0.54 mm; EMT ≥ 0.54 mm (PVO) was identified in 24.2% of the sample and was most frequent in individuals aged 41–55 years. On multivariable logistic regression, age and waist circumference were independently associated with the presence of PVO. Conclusions: Carotid EMT, reflecting the severity of PVAT deposition, may be associated with a wide range of cardiometabolic risk factors in individuals without CVD, with a tentative threshold value of 0.54 mm.

  • Efficacy of the combined use of biopolymer materials to stimulate regeneration of damaged nasal mucosa during surgical interventions

    by M. V. Svistushkin, G. N. Nikiforova, V. I. Sevastianov, N. V. Perova, N. B. Serejnikova, I. A. Zinchenko, A. B. Maltsev, A. A. Platonova, V. A. Kudryavtseva, P. I. Lazareva, et al.

    Introduction . A common problem in sinonasal surgery is intraoperative tearing of the nasal cavity mucosa, resulting in impaired microcirculation in the mucoperichondrium and subsequent complications, including nasal septal perforation. Current clinical correction methods do not always ensure complete tissue restoration, underscoring the need for new approaches to repair damaged nasal mucosa. Aim . To assess the potential of the combined use of two bioresorbable implants – a collagen-containing microheterogeneous hydrogel (an extracellular matrix biomimetic) and a biopolymer membrane based on a bacterial copolymer – for repair of full-thickness nasal septal defects and prevention of postoperative perforations in an experimental animal model. Materials and methods . The study was conducted in 12 rabbits in which a full-thickness nasal septal defect model was created. The animals were assigned to two groups: an experimental group (n = 6) and an untreated control group (n = 6). Intact specimens (n = 6) were obtained from a biobank. In the experimental group, the defect was closed using resorbable bioimplants. The animals were followed up with endoscopic monitoring. On day 30, the animals were withdrawn from the experiment, and the tissues were subjected to morphological examination. Results . In the control group, no defect closure was observed by day 30; the defects increased in size, and synechiae developed in 33% of cases in the area of injury. In the experimental group, complete restoration was achieved in 50% of animals; in the remaining cases, a marked reduction in defect size was observed. Morphological examination in the experimental group demonstrated complete epithelialization, formation of mature cartilage, less pronounced inflammation and fibrosis, and more physiological vascularization compared with controls (p < 0.05). Conclusions . Combined application of a hydrogel extracellular matrix biomimetic and a biopolymer membrane in nasal mucosal defects promotes more complete anatomical and morphological tissue restoration, reduces the risk of postoperative complications, and supports formation of tissue morphologically close to the intact nasal septum.

  • A contemporary view of the treatment of allergic rhinitis patients: When standard therapy isn’t enough

    by V. M. Svistushkin, G. N. Nikiforova, A. N. Shustrova, Zh. T. Mokoyan, E. Yu. Rybakova, E. N. Bobrikova

    Allergic rhinitis (AR) is one of the most common chronic diseases of the upper respiratory tract, in which a focus of inflammation forms in the mucous membrane of the nasal cavity. Pathogenetically, inflammation in the nasal cavity is caused by the development of immediate-type hypersensitivity involving IgE, the so-called T2 inflammation. The diagnosis of AR is a multidisciplinary task. The treatment of AR is a complex of measures, including elimination therapy, drug treatment and allergen-specific immunotherapy. An important aspect of the management of such patients is their training in order to manage the disease. Currently, one of the most modern areas of therapy for AR patients is the use of biological therapy, namely monoclonal antibodies. Monoclonal antibodies have proven their safety and effectiveness in the treatment of various diseases based on the results of numerous studies. The clinical recommendations of the Ministry of Health of the Russian Federation recommend the use of omalizumab for the treatment of patients with severe persistent rhinitis or severe exacerbation. The results of clinical studies have demonstrated that the addition of omalizumab to standard therapy for patients with AR is well tolerated and more effective than traditional treatment. There was a marked reduction in nasal and ophthalmological symptoms, a clinically significant improvement in quality of life and a decrease in the impact of the disease on daily activities and labor productivity. An observation of a patient presenting with AR, allergic conjunctivitis, and bronchial asthma revealed a positive clinical and functional response to genetically engineered biological therapy. This improvement was documented through validated questionnaires, detailed patient history, and comprehensive otorhinolaryngological examination.

  • Possibilities of pathogenetic treatment of rhinosinusitis patients: Efficacy and safety of phytotherapy

    by V. M. Svistushkin, G. N. Nikiforova, E. A. Shevchik, A. V. Zolotova, Kh. M. Asevova

    Rhinosinusitis is a common group of inflammatory diseases of the nose and paranasal sinuses that have a significant impact on the health and quality of life of patients. Despite the frequent appointment of systemic antibiotic therapy for rhinosinusitis, this etiotropic treatment is not indicated in most patients, and pathogenetic treatment is rational in almost all clinical cases. To evaluate the efficacy and safety of phytotherapy, including the standardized drug myrtol, in the treatment of patients with rhinosinusitis according to literature data. A literature review was performed using the databases PubMed, Scopus, eLIBRARY. RU and Cochrane Library for the keywords: “rhinosinusitis”, “phytotherapy”, “Myrtol standardized extract”, “pathogenetic treatment”. Both experimental studies and clinical observations are considered. It has been demonstrated that systemic antibiotic therapy is indicated only in a small proportion of patients with rhinosinusitis who have a moderate to severe bacterial process. The main focus is on pathogenetic treatment, including mucoactive, anti-inflammatory and secretolytic drugs. Phytotherapy, in particular standardized myrtol extract, demonstrates evidence of improved mucociliary clearance, decreased inflammatory response, and symptom relief in the experiment. Clinical studies confirm the safety and efficacy of standardized myrtol extract in acute and chronic rhinosinusitis, with minimal risk of adverse events. Pathogenetic treatment using standardized phytotherapy is a promising method of managing patients with rhinosinusitis. Standardized myrtol extract can be recommended as a safe and effective drug, especially in patients without indications for systemic antibiotics.

  • Possibilities of combined endaural therapy in pain management in acute otitis media: Clinical evaluation

    by V. M. Svistushkin, G. N. Nikiforova, Kh. M. Asevova, A. N. Shustrova, E. V. Sinkov

    Acute otitis media remains one of the most common inflammatory diseases of ENT organs in children and adults, which is accompanied by severe pain syndrome, hearing impairment and reduced quality of life. Modern approaches focus on rational pharmacotherapy using topical drugs to quickly relieve clinical symptoms. Clinical observations of patients with acute otitis media at the pre-perforation stage are presented. The diagnosis was based on complaints, medical history and otorhinolaryngological examination. Patients were treated topically with combination of phenazone and lidocaine. The effectiveness of therapy was assessed by the dynamics of pain syndrome and the regression of inflammatory changes in the eardrum. Particular attention was paid to the tolerability of treatment and the identification of possible adverse events. The use of lidocaine and phenazone provided a rapid reduction in the intensity of pain syndrome: patients noted relief within a few minutes after instillation. Within 4–7 days of therapy, a pronounced regression of inflammatory symptoms was observed. No adverse reactions were detected during treatment. lidocaine and phenazone is an effective and safe tool for endaural therapy of patients with acute otitis media, providing quick relief of pain and reducing the severity of the inflammatory process.

  • Experimental study of a collagen-containing extracellular matrix biomimetic for the restoration of structural properties of the vocal folds after surgical treatment of scarring

    by Mikhail V. Svistushkin, Galina N. Nikiforova, Nadezhda V. Perova, Anzhelika A. Platonova, Igor A. Zinchenko, Natalya B. Serejnikova, Valery M. Svistushkin, Сережникова Наталья Борисовна

    BACKGROUND: Vocal fold scarring remains a substantial and challenging problem in otorhinolaryngology. Current treatment modalities are unable to restore the native morphology and, consequently, the vibratory properties of damaged vocal folds. In this regard, regenerative medicine technologies represent a promising direction for further development. AIM: To evaluate the efficacy of a collagen-containing extracellular matrix biomimetic in the restoration of scar lesions of the vocal folds in an experimental animal model. METHODS: The experimental study was performed on 12 Soviet Chinchilla laboratory rabbit models of vocal fold scarring. Three months after injury, animals with damaged left vocal folds were divided into two groups (n = 6 each). In the experimental group, surgical scar excision was followed by injection of the bioimplant into the defect area; in the control group, only surgical excision of the scar was performed. The right vocal folds of all rabbits were used as an intact group (n = 12). Animals were monitored over time with endoscopic control. Three months after surgery, animals were euthanized, and vocal fold specimens were subjected to histological examination. RESULTS: In the experimental group receiving the bioimplant injection, the resulting scar was subtle and almost indistinguishable from native vocal folds. The thickness of the formed scar was twofold lower than in the control group (p 0.0001). Morphological assessment demonstrated that the structure of the vocal folds in the experimental group was comparable to intact specimens. Enhanced epithelialization of the mucosa and cartilage regeneration, less pronounced inflammatory changes and tissue fibrosis, and physiologic vascularization of the defect area were observed in the animals of the experimental group. CONCLUSION: Implantation of a collagen-containing extracellular matrix biomimetic into the area of vocal fold injury promotes improved healing of the defect and formation of tissue morphologically closer to healthy vocal folds.


  • Open Access

    Current treatment of pharyngeal diseases

    by L.S. Karapetyan, Г. Н. Никифорова, Л. Г. Гафурова

    Background. Pathology of ENT organs has an important medical and social significance, which is explained by the impact on a number of indicators characterizing the level of quality of life. The increase in life expectancy of the population leads to the fact that otolaryngological complaints come to the forefront in the practice of doctors. Analysis of ENT diseases, conducted by a number of domestic and foreign researchers, indicates a high level of both acute and chronic diseases: in 1st place – diseases of the throat, in 2nd place – diseases of the nose and paranasal sinuses, in 3rd place – diseases of the ear, in 4th place – diseases of the larynx. A tendency was noted for more frequent registration of diseases of the ear, throat, nose in men compared to women. Most often, patients who received medical care were in the age range of 18-30 years. Thus, diseases of the throat occupy the first place in the structure of ENT diseases. There is an annual increase in infectious and inflammatory diseases of the pharynx, and despite the fact that most of these diseases do not require systemic antibacterial therapy, they significantly reduce the quality of life of patients and require treatment. Local drugs for the treatment of sore throat are preferable for both patients and doctors due to their ease of use and fewer side effects. A separate large group consists of patients who have undergone surgical treatment of pharyngeal diseases (tonsillectomy, adenotomy, various types of uvulopalatoplasty), who have severe pain syndrome persists in the early postoperative period and who need local treatment. Conclusion. This article discusses the main diseases of the pharynx, diagnostic and treatment methods. Particular attention is paid to promising new methods of topical treatment. The pharmacological properties, mechanism of action, indications for use, as well as clinical aspects and prospects for the use of the topical antiseptic ambazone monohydrate in the practice of an otolaryngologist are considered.

  • Open Access

    Postoperative management of patients after bilateral tonsillectomy

    by Alexey V. Toldanov, Galina N. Nikiforova, Mikhail V. Svistushkin, Evgeniia D. Kulikova, Anastasia V. Guryleva, Alexander S. Machikhin, Valery M. Svistushkin, Мачихин Александр Сергеевич

    Background. Chronic tonsillitis is a chronic disease with local manifestations in the form of a persistent inflammatory reaction of the palatine tonsils, a fairly common pathology in the human population. In some cases, such patients are shown and undergoing surgical intervention – bilateral tonsillectomy (BT), the most serious complication of which is bleeding from the amygdala niches. Unfortunately, modern measures aimed at preventing and stopping bleeding do not always adequately solve this problem. The topic of postoperative control and acceleration of regenerative processes after removal of palatine tonsils remains relevant. Aim. To evaluate the effect on the course of the wound process after BT of the use of a topical complex hemostatic drug based, among other things, on the results of digital optical methods for assessing blood supply. Materials and methods. The study was conducted at the Clinic of Ear, Throat and Nose Diseases at Sechenov First Moscow State Medical University (Sechenov University). The study included 140 (100%) patients aged 18 to 66 years, including 60 (42%) men and 80 (57%) women who underwent BT for medical reasons. A 1% aqueous solution of an incomplete silver salt of polyacrylic acid containing silver nanoparticles was used as a complex hemostatic preparation. All observed patients were divided into 3 groups: a control group 1 without the use of the drug, a group 2 with topical intraoperative use of the drug, a group 3 with topical intraoperative and postoperative use of the drug. All patients underwent pain assessment using the Wong–Baker visual analogue facial pain scale, cytological examination from the surface of the amygdala niche, and digital visual assessment of the condition of the postoperative field. Contactless photoplethysmography was used as a digital optical method for assessing blood supply. Results. The study showed a decrease in pain in the pharynx, an increase in bacterial phagocytosis, an acceleration of fibrin release, the appearance of fibroblasts and the transition of the leukocyte reaction to polymorphocellular in both groups with topical application of the studied drug. The severity of these effects was higher in patients who received intraoperatively and in the postoperative period. The possibility of carrying out a noninvasive quantitative assessment of blood filling of the oral mucosa tissues, which are difficult to access for traditional imaging methods, without causing discomfort to the patient is demonstrated. The proposed approach can complement the existing methods of managing patients after BT in clinical practice. Conclusion. In clinical conditions, the effectiveness and safety of a new integrated approach to the management of patients after BT, based on the use of the hemostatic drug Hemoblock to prevent bleeding and accelerate regeneration, as well as the photoplethysmography method for noninvasive quantitative assessment of blood filling of amygdala niches in the postoperative period, has been demonstrated.

  • Open Access

    What is hidden under the mask of chronic suppurative otitis media? Clinical case

    by Valerii M. Svistushkin, Galina N. Nikiforova, Elena A. Shevchik, Anna V. Zolotova, Anna R. Mironova

    Chronic suppurative otitis media (CSOM) is a common pathology in the practice of an otolaryngologist. Modern conservative therapy and surgical correction methods have made it possible to achieve good functional results. However, in some cases, standard treatment is ineffective, then such a course of CSOM is usually called ”atypical”. Under its mask, a number of systemic diseases may be hidden, which are accompanied by inflammatory changes in the cavities of the middle ear. The article describes a clinical case of ”atypical” bilateral purulent otitis media in a female patient. During surgical treatment, morphological features were noted indicating a possible specific nature of inflammation in the middle ear. During further examination by a phthisiatrician, a tuberculoma of the right lung was detected, chemotherapy was started, during which, after 4 months, the symptoms of exacerbation of CSOM were stopped. Thus, an interdisciplinary approach is necessary for diagnosis and correct tactics of management of patients with ”atypical” sluggish CSOM.